MOONLAKE IMMUNO (MLTX)
(Delayed Data from NSDQ)
$8.66 USD
+0.23 (2.73%)
Updated Oct 6, 2025 04:00 PM ET
After-Market: $8.77 +0.11 (1.27%) 7:48 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
MoonLake Immunotherapeutics's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
MLTX 8.66 +0.23(2.73%)
Will MLTX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for MLTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MLTX
MLTX Stock Gains 18% as Merck Reportedly Eyes Buyout
Wall Street Analysts Think MOONLAKE IMMUNO (MLTX) Could Surge 106.62%: Read This Before Placing a Bet
MLTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MLTX
Top 3 Health Care Stocks That Are Preparing To Pump In Q4
LifeSci Capital Reaffirms Their Buy Rating on MoonLake Immunotherapeutics (MLTX)
Is MLTX building bearish momentum? 1,2,3 Retracement Bearish shows up after soaring 13.0%
Unusually active option classes on open October 3rd
Unusually active option classes on open October 3rd